The 18th Annual Meeting of MCBIOS with the theme of “AI and Data Science in Drug Development and Public Health” will be held in conjunction with the 5th Annual Conference of MAQC Society with the theme of “Reproducibility and Explainable AI in Public Health”.
I am pleased to announce the 2022 MCBIOS-MAQC Joint Conference on Computational Biology, Bioinformatics, and Reproducible Data Science to be held on the campus of SAS Institute, Inc. Cary, North Carolina, USA during April 25-29, 2022.
We welcome you to submit a proposal for a scientific session (normally 90 minutes each) at MCBIOS 2022 by adopting one of these following formats:
The joint conference will be hybrid (in-person and virtual attendance) with MCBIOS 2022 on April 25-26 and a joint poster session on April 27 and MAQC 2022 to continue on April 28-29.
MCBIOS 2022 will feature late-breaking research on data science and artificial intelligence applied to disease biology modeling, genomics, systems biology studies, translational bioinformatics, computational drug development, and clinical informatics applications to improve public health.
MCBIOS is committed to training young scientists from diverse educational and ethnic backgrounds. Again, we will be glad to offer Young Scientist Excellence Awards, Poster Awards, and Travel Assistance to our members. More information about the eligibility, selection criteria, and deadlines will be updated on the MCBIOS web site. Please spread the word about this exciting in-person/virtual conference of MCBIOS 2022. We look forward to supporting Dr. Joshua Xu whole-heartedly in his organizing of this annual conference. And we look forward to your participation!
Jake Y. Chen, PhD, FACMI, FAIMBE, FAMIA
President, Midsouth Computational Biology and Bioinformatics Society (MCBIOS)
November 15, 2021
November 30, 2021
December 15, 2021
January 1, 2022
February 15, 2022
March 15, 2022
April 20, 2022
April 25-27, 2022
This conference is being held in conjunction with the Massive Analysis And Quality Control Society (MAQC) annual meeting.
Since 2005, the FDA has led the MicroArray Quality Control (MAQC) consortium, which is a community wide effort to address reproducibility issues relating to the application of constantly evolving high‐throughput genomics technologies to either assess safety and efficacy of FDA regulated products and their safe and effective use in clinical applications. The MAQC consortium completed three projects between 2005 ‐2014 (namely MAQC I, II and III), resulting in ~30 publications. Its fourth project, also called SEquencing Quality Control Phase II (SEQC II) project will be completed in 2021. The MAQC Society is derived from the MAQC consortium.ABOUT MAQC